Bayer disagrees with German Government decision to ban Glyphosate from end of 2023 Medical Dialogues Bureau6 Sept 2019 9:00 AM IST"Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
Dr Reddys unveils generic version of Zyban ER tablets in US Medical Dialogues Bureau5 Sept 2019 5:01 PM ISTThe company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm Medical Dialogues Bureau5 Sept 2019 9:15 AM ISTZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report Medical Dialogues Bureau5 Sept 2019 9:00 AM ISTBilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI Medical Dialogues Bureau4 Sept 2019 5:18 PM ISTNew Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
Former JnJ executive Marianne De Backer to lead Bayer pharma division Medical Dialogues Bureau4 Sept 2019 9:30 AM ISTMarianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab Medical Dialogues Bureau3 Sept 2019 10:00 AM IST"The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sept 2019 8:58 AM ISTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sept 2019 4:34 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court Medical Dialogues Bureau2 Sept 2019 9:30 AM ISTThe IPR is seeking to invalidate new patents covering the composition of the main ingredient of Soliris, eculizumab, its formulation, and its use to...
AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business Farhat Nasim31 Aug 2019 2:35 PM ISTNew Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
